| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.27 | 4e-06 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |